Adage Capital Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-5,000
Closed -$668K – 992
2025
Q3
$668K Buy
+5,000
New +$607K ﹤0.01% 840
2024
Q4
– Sell
-100,000
Closed -$14.9M – 947
2024
Q3
$14.9M Buy
100,000
+50,000
+100% +$7.17M 0.03% 530
2024
Q2
$6.3M Sell
50,000
-65,000
-57% -$10.2M 0.01% 683
2024
Q1
$21.2M Buy
+115,000
New +$21.9M 0.04% 434
2022
Q1
– Sell
-40,000
Closed -$10.6M – 1121
2021
Q4
$10.6M Buy
+40,000
New +$10.8M 0.02% 674

Other funds holding RGEN

Adage Capital Partners's RGEN Position: Q4 2025 in Review

Adage Capital Partners sold out of Repligen (RGEN) in Q4 2025, closing a stake of 5,000 shares — an estimated $668K sold.

Adage Capital Partners first reported a position in RGEN in Q4 2021 and held it in 5 quarters. The position peaked at $21.2M in Q1 2024. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Adage Capital Partners reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Adage Capital Partners sold 5,000 Repligen shares in Q4 2025, an estimated $668K.
  • Adage Capital Partners first reported a position in Repligen in Q4 2021 and held it in 5 quarters.
  • Adage Capital Partners's Repligen position peaked at $21.2M in Q1 2024.
  • 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Adage Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.